Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor
Rechallenge of Imatinib in GIST Having no Effective Treatment
Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy
Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
† Study has passed its completion date and status has not been verified in more than two years.